Training of young scientists in the Biological regulation of the chemokine network to improve treatment of ACTIVE inflammation

Informazioni relative al progetto

B-ACTIVE

ID dell’accordo di sovvenzione: 101120187

DOI

10.3030/101120187

Data della firma CE 5 Luglio 2023

Data di avvio 1 Gennaio 2024

Data di completamento 31 Dicembre 2027

Finanziato da

• Marie Skłodowska-Curie Actions (MSCA)

Costo totale

Nessun dato

Contributo UE

€ 2 800 864,80

Coordinato da

KATHOLIEKE UNIVERSITEIT LEUVEN
Belgium

CORDIS fornisce collegamenti ai risultati finali pubblici e alle pubblicazioni dei progetti ORIZZONTE.

I link ai risultati e alle pubblicazioni dei progetti del 7° PQ, così come i link ad alcuni tipi di risultati specifici come dataset e software, sono recuperati dinamicamente da .OpenAIRE .

Risultati finali

Websites, patent fillings, videos etc. (1)

Website

Project website

Documents, reports (5)

Report on reference preparations of CCL3L1 and CCL5

Preparation of proteoforms of the chemokines CCL3L1 and CCL5 by chemical synthesis or recombinant expression

Advertising vacancies

Vacancies for the planned recruitment of ESR advertised

Report on reference preparations of CCL2 and CCL3

Preparation of proteoforms of the chemokines CCL2 and CCL3 by chemical synthesis or recombinant expression

B-ACTIVE public announcement

Public announcement of the start of B-ACTIVE

Report on the optimization of flow cytometry panels

Optimization of antibody panels for analysis of patient samples by flow cytometry

Pubblicazioni

Peer reviewed articles (4)

Activation of cytomegalovirus-encoded G protein-coupled receptor UL33 by an innate N-terminal peptide

Autori: Anna K. Drzazga, Shota Suzuki, Caroline Wouters, Felix Faas, Kouki Nishikawa, Akiko Kamegawa, Yoshinori Fujiyoshi, Mette M. Rosenkilde, Naotaka Tsutsumi
Pubblicato in: Communications Biology, 2026, ISSN 2399-3642
Editore: Springer Science and Business Media LLC
DOI: 10.1038/S42003-026-09660-5

Neutrophils as critical orchestrators of chronic inflammation

Autori: Kaat Torfs, Gaël Vermeersch, Mieke Gouwy, Timothy Devos, Paul Proost, Sofie Struyf
Pubblicato in: Cellular & Molecular Immunology, 2026, ISSN 2042-0226
Editore: Springer Science and Business Media LLC
DOI: 10.1038/S41423-025-01380-W

Improving the in vivo activity of glycosaminoglycan-binding immunomodulatory drugs by fusion to human serum albumin

Autori: Fabio Beretta, Lotte Agten, Vivian Louise Soares de Oliveira, Nele Berghmans, Christina Trojacher, Aid Atlic, Johannes Almer, Sofie Struyf, Roland Weis, Paul Proost, Andreas J. Kungl
Pubblicato in: International Journal of Biological Macromolecules, Numero 339, 2026, ISSN 0141-8130
Editore: Elsevier BV
DOI: 10.1016/J.IJBIOMAC.2025.149825

Chemokines in the resolution of inflammation: key players and targets for therapeutic modulation

Autori: Vivian Louise Soares Oliveira, Paul Proost, Sofie Struyf
Pubblicato in: Frontiers in Immunology, Numero 16, 2025, ISSN 1664-3224
Editore: Frontiers Media SA
DOI: 10.3389/FIMMU.2025.1717666